MENLO PARK, Calif., Sept. 12 XTENT, Inc.(Nasdaq: XTNT) today announced that Timothy D. Kahlenberg, Chief FinancialOfficer, will present at the 4th annual Merriman Curhan Ford & Co. InvestorSummit on Monday, September 17, 2007 at 10:45 a.m. Pacific. This event willbe held at the Mark Hopkins InterContinental Hotel in San Francisco. Therewill also be a webcast available at http://www.wsw.com/webcast/mcm7/xtnt/.
XTENT, Inc. is a medical device company focused on developing andcommercializing innovative customizable drug eluting stent (DES) systems forthe treatment of coronary artery disease (CAD). CAD is the most common form ofcardiovascular disease and the number one cause of death in the United Statesand Europe. XTENT(R) Custom NX(R) DES Systems are designed to enable thetreatment of single lesions, long lesions and multiple lesions of varyinglengths and diameters, in one or more arteries with a single device. Note:XTENT(R) Custom NX(R) DES Systems have not been approved for sale by anyregulatory authority.
SOURCE XTENT, Inc.